Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
The European Respiratory Journal|June 27, 2015
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertensionVallerie McLaughlin, Richard N Channick, Hossein-Ardeschir Ghofrani, et al.
Chest|September 17, 2022
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical OutcomesSteven D Nathan, Chunqin Deng, Christopher S King, et al.
Circulation|June 28, 2014
Predicting the risk of venous thromboembolism in patients hospitalized with heart failureAlexandre Mebazaa, Theodore E Spiro, Harry R Büller, et al.
Chest|May 26, 2012
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trialVictor F Tapson, Fernando Torres, Fiona Kermeen, et al.
The International Journal of Cardiovascular Imaging|February 25, 2011
Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED IIIH Dirk Sostman, Kathleen A Jablonski, Pamela K Woodard, et al.
Circulation. Cardiovascular Imaging|December 21, 2018
Clinical Utility and Prognostic Value of Right Atrial Function in Pulmonary HypertensionFawaz Alenezi, Aditya Mandawat, Zachary J Il'Giovine, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseReda E Girgis, Adaani E Frost, Nicholas S Hill, et al.
Cardiovascular Therapeutics|September 14, 2012
Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertensionRobert C Bourge, Victor F Tapson, Zeenat Safdar, et al.
The International Journal of Cardiovascular Imaging|February 22, 2011
Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimegluminePamela K Woodard, Thomas L Chenevert, H Dirk Sostman, et al.
Advances in Therapy|November 2, 2021
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label ExtensionNazzareno Galiè, Sean Gaine, Richard Channick, et al.
Pageof 16